Physician

Luis Guillermo Leon-Alvarado, M.D.

According to 2025 Medicare claims, Luis Leon-Alvarado, M.D. (NPI: 1538447974) practices ophthalmology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 34785-7486.

Leon-Alvarado's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,071 traditional Medicare patients, billed 16,160 HCPCS/CPT codes, and received $1,545,721 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 654 prescription claims across 307 beneficiaries totaling $157,799 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 10 records totaling $303. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $18,252 to $1,545,721. Similarly, Part D prescription costs have moved sharply higher in recent years, from $15,555 to $157,799. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$773K$1.5M2015 Medicare payment: $18,252 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $35,061 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $112,018 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $269,910 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $483,242 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $730,690 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $753,864 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $631,734 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $634,560 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,545,721 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015116292$18,252
2016223628$35,061
20173341,198$112,018
20185422,474$269,910
20197113,168$483,242
20207833,640$730,690
20217963,692$753,864
20228173,604$631,734
20237874,717$634,560
20241,07116,160$1,545,721

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$79K$158K2016 Drug cost: $15,555 (USD; Tot_Drug_Cst)2017 Drug cost: $17,094 (USD; Tot_Drug_Cst)2018 Drug cost: $27,449 (USD; Tot_Drug_Cst)2019 Drug cost: $50,141 (USD; Tot_Drug_Cst)2020 Drug cost: $51,099 (USD; Tot_Drug_Cst)2021 Drug cost: $65,127 (USD; Tot_Drug_Cst)2022 Drug cost: $77,738 (USD; Tot_Drug_Cst)2023 Drug cost: $80,847 (USD; Tot_Drug_Cst)2024 Drug cost: $157,799 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201693275$15,555
201795226$17,094
201894200$27,449
2019143380$50,141
2020211650$51,099
2021212662$65,127
2022260798$77,738
2023235749$80,847
2024307654$157,799

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system288288$105
67028Injection of drug into eye342821$103
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more369432$72
92134Imaging of retina510969$32
92250Photography of the retina702726$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept491,372$114,737
Ketorolac TromethamineKetorolac Tromethamine1143,797$4,313
Prednisolone AcetatePrednisolone Acetate662,968$2,926
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1302,708$1,545
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat846,576$965

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$303Notal Vision, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Luis Guillermo Leon-Alvarado, M.D.?

Tedicare shows public-source Medicare data for Luis Guillermo Leon-Alvarado, M.D. (NPI 1538447974), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Luis Guillermo Leon-Alvarado, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Luis Guillermo Leon-Alvarado, M.D.?

Luis Guillermo Leon-Alvarado, M.D. is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Luis Guillermo Leon-Alvarado, M.D. have Open Payments data?

Luis Guillermo Leon-Alvarado, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.